This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Expanding the potential patient population for pulsed field ablation, results from the SINGLE SHOT CHAMPION study suggest PFA might be just as good as cryoballoon ablation for patients with paroxysmal AFib. The post PFA or Cryoballoon for Paroxysmal AFib? Atrial tachyarrhythmia recurred in 37.1% of the PFA group compared to 50.7%
UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg. age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib. adults would have AFib by 2020. adults would have AFib by 2020. adult population.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time. Piccini, M.D.,
Drinking multiple cups of coffee a day may help prevent cognitive decline in people with atrial fibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association.
(MedPage Today) -- CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain infarcts, according to the BRAIN-AF trial.
(MedPage Today) -- The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.
Research Highlights: Treating gum disease within three months after a heart procedure to correct an irregular heart rhythm, known as atrial fibrillation (AFib), may lower the chances of it reoccurring. Inflamed gums may predict AFib recurrence after.
Treating gum disease in the three months after a procedure to correct an irregular heartbeat known as atrial fibrillation (AFib) may lower oral inflammation and may reduce AFib recurrence, according to new research published today in the Journal of the American Heart Association.
A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
A Cedars-Sinai-led team developed an echocardiography AI model that accurately detects patients with atrial fibrillation – including asymptomatic patients – potentially revealing a new “opportunistic screening” method to drive earlier AFib detection and treatment. AUC identifying patients with a history of AFib.
A BMJ study out of Denmark provided alarming new insights into atrial fibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. The researchers analyzed 2000-2022 data from 3.5M The researchers analyzed 2000-2022 data from 3.5M
Recent research has also found the incidence of atrial fibrillation (AFib), the most common type of irregular heart rhythm or arrhythmia, continues to rise, according to the study. Binge drinking (five drinks within two hours for men and four drinks within two hours for women) is common around the world.
Research Highlights: A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
Fully published results from Athos Therapeutics AZALEA-TIMI 71 trial for its novel Factor XI inhibitor abelacimab, confirming the drugs lower bleeding risks, but leaving researchers uncertain about its ability to prevent stroke in AFib patients. year follow-up. per 100 person-years vs. 0.83).
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Research Highlights: In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline, stroke or transient ischemic attack (TIA) in people younger than age 65 who had atrial fibrillation (AFib).
Atrial fibrillation (Afib), a common type of arrhythmia that is on the rise in people under the age of 65, is more dangerous in this increasingly younger population than previously thought, according to new research.
Evaluating the ACO incentives , researchers compared care quality data from the ACCs NCDR PINNACLE Registry before and 6-12 months after MSSP participation at 83 ACO outpatient cardiology practices versus 332 non-ACO practices and found MSSP ACO participation made no difference in coronary artery disease, HF, AFib, or hypertension outcomes.
Looking at specific substances in the blood of people with atrial fibrillation, a type of irregular heartbeat, could help identify who's at risk for a stroke despite taking blood-thinning medication to prevent one, new research suggests.
One of my New Year's resolutions was to read the entire 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AFib).
Compared with a sham procedure, pulmonary vein isolation resulted in a statistically significant and clinically important decrease in atrial fibrillation (AFib) burden at six months, according to results from the SHAM-PVI trial presented at ESC Congress 2024 in London and simultaneously published in JAMA.
The results support the use of workflows to reduce radiation exposure during catheter ablation for the treatment of paroxysmal atrial fibrillation (AFib) while maintaining safety, efficacy, and long-term patient outcomes comparable to traditional procedures.1 Circulation Research. Int J Stroke. 2021 Feb;16(2):217-221.
Treatment with the Type 2 diabetes medication metformin, lifestyle changes, or a combination of both did not improve atrial fibrillation (AFib) burden or progression when compared with standard care, according to preliminary late-breaking science presented Nov. 18 at the American Heart Association's Scientific Sessions 2024.
Patients with NVAF deemed appropriate for LAAX to reduce the risk of stroke and systemic embolism, will participate in this research effort. Atrial fibrillation ( AFib ) affects approximately 38 million patients globally, significantly increasing the risk of stroke1,2. The The acquisition of Laminar, Inc.
Research is needed to determine the implications of these alarms and appropriate follow-up. In total, 5 cases of AF were diagnosed with 1 additional case identified during EHR review. Conclusion Wearable devices produce alarms that can frequently be anxiety provoking.
Abstract Introduction Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
The AI lineup currently covers both continuous ECG tracking and AFib detection. Mobihealth News spoke with Yuichi Tamura, CEO of Cardio Intelligence, who discussed more about their latest work in detecting AFib and how they are helping Japan shed light on this silent threat. You are currently developing a new AI to detect AFib.
Our study assesses the safety and efficacy of low-dose apixaban compared to a full-dose in patients with AF who had GIB over the course of 5 years.Methods:We queried the US Collaborative Network (which contains 63 healthcare organizations) of TriNetX deidentified research database. After PSM, each cohort included 3,701 patients.
11, 2025, at HonorHealth Research Institute, Rahul Doshi, M.D., Using the same catheter, he also was able to easily switch to radiofrequency ablation, which has traditionally been used to treat Afib by scarring the damaged part of the heart using heat. Learn more at HonorHealth.com/research. 12, 2025 On Feb. of the adult U.S.
19, 2024 Drinking multiple cups of coffee a day may help prevent cognitive decline in people withatrial fibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association. Many myths are around, but our study found no reason to discourage or forbid a patient with AFib from drinking coffee.
OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers. Kingshott, R. 2017, November 8).
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyze and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. Fertile Partnerships Ongoing research partnerships have driven much of recent developments seen in the market.
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. Circulation Research.
The researchers analyzed data from 7,970 VA patients who were diagnosed with HFpEF between 2002 to 2016, and didn’t have known ASCVD or a history of statin use at baseline. This new study looked to further establish statins’ HFpEF impact. The post Could Statins Be The Next Breakthrough HFpEF Treatment?
Image courtesy: Getty Images christine.book Sat, 05/18/2024 - 14:26 May 18, 2024 — The Heart Rhythm Society ( HRS ) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation ( AFib ).
Atrial fibrillation (AFib) cases have also surged, doubling from 28.3 Research points to low patient engagement as a predictive indicator of poor outcomes. Their adoption is crucial to counteracting the rising prevalence of strokes, AFib and other diseases that place immense pressure on already constrained providers.
Researchers analyzed 840 REDUCE-IT participants (10.3% However, like the original REDUCE-IT trial, IPE had higher treatment-related rates of AFib or flutter (7.4% absolute risk reduction for experiencing a first composite primary event (18.7% vs. 28%) and had a “number needed to treat” to avoid a primary event of 11 patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content